Does excess dosing of antithrombotics increase the risk of major bleeding?
Rebecca Ireland
This article has no abstract so we have provided the first paragraph of the full text.
Given concern about bleeding risk with use of antithrombotic therapy, Alexander et al. investigated whether unintentional excess dosing of adjustable anticoagulants, specifically unfractionated heparin (UFH), low-molecular-weight heparin (LMWH), or glycoprotein IIb/IIIa inhibitors, affects outcomes of patients with non-ST-segment elevation acute coronary syndromes.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
